Pulmonary Drug Delivery Devices Market

Pulmonary Drug Delivery Devices Market (Product Type: Dry Powder Inhalers, Metered Dose Inhalers, and Nebulizers; Application: Asthma, COPD, and Cystic Fibrosis) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Market Outlook 2031

  • The global pulmonary drug delivery devices market size stood at US$ 37.2 Bn in 2022
  • It is expected to increase at a CAGR of 4.4% from 2023 to 2031 and reach US$ 55.0 Bn by the end of 2031

Analysts’ Viewpoint

Pulmonary drug delivery is considered as a better alternative to oral delivery. It is being increasingly preferred due to the direct dissemination of drugs to the affected areas. Rise in incidence of chronic respiratory diseases, such as asthma, chronic obstructive pulmonary disease, and cystic fibrosis, is projected to significantly boost the pulmonary drug delivery devices market growth during the forecast period.

Development of smart and digital inhalers and expansion of distribution network due to significant growth of e-commerce sector are likely to offer lucrative pulmonary drug delivery devices market opportunities for manufacturers across the globe. Furthermore, easy availability of pulmonary drug delivery devices in retail pharmacies and e-pharmacies is expected to have a positive impact on the market outlook.

Global Pulmonary Drug Delivery Devices Market

Market Introduction

Pulmonary drug delivery systems have been in medical use for over six decades and are employed to administer drugs through the pulmonary route in order to treat diseases such as asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis. Growing incidence and awareness about respiratory disorders is leading to advancements in pressurized metered-dose inhalers and integration of nanotechnology in pulmonary drug delivery. This is estimated to drive the demand for inhalation drug administration tools in the near future.

Training and understanding of usage of nasal drug delivery techniques and devices are essential for patients, despite awareness about the benefits breath-activated inhalers. This is expected to hamper the adoption of drug delivery devices. Furthermore, stringent regulatory framework and approval processes are likely to restrain organic growth of the market. Additionally, higher prices of these devices are estimated to further hinder market progress.

Rise in Prevalence of Chronic Respiratory Diseases to Boost Pulmonary Drug Delivery Devices Market Demand

Growing pollution and prolonged exposure to harmful gases, tobacco smoke, fumes, and chemicals are key factors driving the prevalence of respiratory diseases. According to the World Health Organization, around 7 million people die every year due to indoor and outdoor pollution, while around 90% of the people breathe polluted air. Therefore, rise in number of deaths occurring due to pulmonary diseases is anticipated to positively impact the market outlook in the next few years.

According to the World Health Organization, in 2019, COPD was the third-leading cause of death, and it led to around 3.23 million deaths across the globe. It further states that the year 2020 recorded over 2.2 million new cases of lung cancer with 1.8 million fatalities. Moreover, around 262 million people across the globe were affected with asthma in 2019, and it caused 461,000 deaths in the same year.

Rapid urbanization and changing lifestyle are key factors driving the prevalence of asthma. Furthermore, surge in awareness about the management of asthma and easy availability of pulmonary drug delivery systems or devices are driving market progress.

Increase in Preference for Convenience in Route of Delivery to Drive Pulmonary Drug Delivery Devices Market Revenue

Pulmonary drug delivery facilitates direct administration of drugs to the disease site. These devices as highly preferred for patients who may be unable to administer medication through the oral route. Moreover, certain patients have the tendency of through up, or vomit, after intake of medication orally. On the contrary, pulmonary drug delivery facilitates quick onset with negligible systemic side-effects.

In October 2022, Aptar Digital Health strategically partnered with the Chiesi Group to introduce a disease management platform for COPD and asthma. Furthermore, In July 2020, Teva Pharmaceutical Industries Ltd. announced that it had tabled a Bluetooth-enabled version of ProAir albuterol sulfate rescue inhaler. Therefore, integration of technology and advances in pulmonary drug delivery devices are expected to ease administration of doses for patients and consequently, boost their adoption in the near future.

Regional Pulmonary Drug Delivery Devices Market Forecast

North America accounted for the largest pulmonary drug delivery devices market share in 2022 due to growing incidence of respiratory diseases, such as COPD, allergic rhinitis, and asthma. Additionally, National Asthma Control Program (NACP) from CDC is funding initiatives to create awareness about asthma. This is estimated to boost the adoption of pulmonary medication dispensers in the region.

Rapid urbanization and industrialization in developing economies in Asia Pacific are elevating pollution levels across the region. Increase in pollution is a key factor driving the prevalence of respiratory diseases. This, in turn, is boosting the adoption of respiratory medication delivery devices across the region. Moreover, growing awareness about the safety and convenience involved with pulmonary drug delivery devices is projected to rapidly drive the pulmonary drug delivery devices industry growth in Asia Pacific in the near future.

Analysis of Key Players

Leading players in the pulmonary drug delivery devices industry are engaged in various modes of expansion such as new product launch, mergers, acquisitions, partnerships, and joint ventures to consolidate their presence in the global market. Major companies are following the latest pulmonary drug delivery devices market trends to develop advanced devices and cater to customer need worldwide. A few prominent players operating in the global market are AstraZeneca Plc, Novartis AG, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd.

Key Developments

  • In May 2023, Hovione signed a strategic partnership agreement with H&T Presspart for advancing development of Sunriser Capsule-based Dry Powder Inhaler platform. This capsule-based platform claims flexibility regarding addressing challenges pertaining to spray-dried and carrier-based engineered formulations.
  • In April 2023, PureIMA announced securing a new-fangled investment round through Boost-UP Foundation. The objective is to develop large and small molecules for systemic indications.
  • In March 2023, Stevanato Group S.p.A. announced a collaboration with Recipharm to lend manufacturing experience to support production and development of pre-filled syringes for usage in the latter’s soft mist inhalers
  • In September 2022, RIGImmune inked a deal to acquire Subintro, thereby providing it an access to new topical delivery systems. This deal facilitated the development of new vaccine adjuvants and RNA therapies for local mucosal delivery.
  • In April 2022, GlaxoSmithKline Pharmaceuticals launched Trelegy Ellipta, a type of once-daily single-inhaler triple therapy (SITT), to treat patients suffering from COPD, in India

Key players in the pulmonary drug delivery devices market report have been profiled based on various parameters such as company overview, business strategies, financial overview, product portfolio, and business segments.

Pulmonary Drug Delivery Devices Market Snapshot

Attribute Detail
Market Value in 2022 (Base Year) US$ 37.2 Bn
Market Forecast Value in 2031 US$ 55.0 Bn
Growth Rate (CAGR) 4.4%
Forecast Period 2023-2031
Quantitative Units US$ Bn for Value and Million Units for Volume
Market Analysis Qualitative analysis includes drivers, restraints, opportunities, key trends, key market indicators, Porter’s Five Forces analysis, value chain analysis, and SWOT analysis. Furthermore, at the regional level, the qualitative analysis includes key trends, price trends, and key supplier analysis.
Competition Landscape Prominent Players - Competition Dashboard and Revenue Share Analysis, 2022 Company Profiles (Details - Company Overview, Sales Area/Geographical Presence, Revenue, Strategy & Business Overview)
Regions Covered
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Market Segmentation
  • Product Type
    • Dry Powder Inhalers
    • Metered Dose Inhalers
    • Nebulizers
  • Application
    • Asthma
    • COPD
    • Cystic Fibrosis
  • Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
    • e-Commerce
Companies Profiled
  • AstraZeneca Plc
  • Novartis AG
  • Boehringer Ingelheim GmbH
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.
  • Teva Pharmaceutical Industries Ltd.
Scope for Customization Available upon Request
Pricing Available upon Request

Frequently Asked Questions

How big was the pulmonary drug delivery devices market in 2022?

The global market was valued at US$ 37.2 Bn in 2022

How is pulmonary drug delivery devices industry expected to grow during the forecast period?

It is projected to grow at a CAGR of 4.4% from 2023 to 2031

What are the key factors driving the demand for pulmonary drug delivery devices?

Rise in prevalence of chronic respiratory diseases and increase in preference for convenience in route of delivery

Which pulmonary drug delivery devices segment held largest share in 2022?

In terms of distribution channel, the retail pharmacies segment held largest share in 2022

Which region is expected to dominate the pulmonary drug delivery devices business?

North America is estimated to dominate the global business in the next few years

Who are the key pulmonary drug delivery devices manufacturers?

AstraZeneca Plc, Novartis AG, Boehringer Ingelheim GmbH, GlaxoSmithKline Plc, Merck & Co., Inc., and Teva Pharmaceutical Industries Ltd.

    1. Executive Summary

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Pulmonary Drug Delivery Devices Market

    4. Market Overview

        4.1. Market Segmentation

            4.1.1. Segment Definition

            4.1.2. Industry Evolution / Developments

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, 2023-2031

    5. Key Insights

        5.1. Pipeline Analysis

        5.2. Disease Prevalence & Incidence Rate Globally With Key Countries

        5.3. COVID-19 Pandemic Impact on Industry

    6. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Product Type

        6.1. Introduction and Definitions

        6.2. Key Findings/Developments

        6.3. Market Value & Volume Forecast, by Product Type, 2023-2031

            6.3.1. Dry Powder Inhalers

            6.3.2. Metered Dose Inhalers

            6.3.3. Nebulizers

        6.4. Market Attractiveness, by Product Type

    7. Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Application

        7.1. Introduction and Definitions

        7.2. Key Findings/Developments

        7.3. Market Value & Volume Forecast, by Application, 2023-2031

            7.3.1. Asthma

            7.3.2. COPD

            7.3.3. Cystic Fibrosis

            7.3.4. Others

        7.4. Market Attractiveness, by Application

    8. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Distribution Channel

        8.1. Introduction and Definitions

        8.2. Key Findings/Developments

        8.3. Market Value & Volume Forecast, by Distribution Channel, 2023-2031

            8.3.1. Retail Pharmacies

            8.3.2. Hospital Pharmacies

            8.3.3. E-Commerce

        8.4. Market Attractiveness, by Distribution Channel

    9. Global Pulmonary Drug Delivery Devices Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value & Volume Forecast, by Region, 2023-2031

            9.2.1. North America

            9.2.2. Europe

            9.2.3. Asia Pacific

            9.2.4. Latin America

            9.2.5. Middle East & Africa

        9.3. Market Attractiveness, by Region

    10. North America Pulmonary Drug Delivery Devices Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value & Volume Forecast, by Product Type, 2023-2031

            10.2.1. Dry Powder Inhalers

            10.2.2. Metered Dose Inhalers

            10.2.3. Nebulizers

        10.3. Market Attractiveness, by Product Type

        10.4. Market Value & Volume Forecast, by Application, 2023-2031

            10.4.1. Asthma

            10.4.2. COPD

            10.4.3. Cystic Fibrosis

            10.4.4. Others

        10.5. Market Attractiveness, by Application

        10.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031

            10.6.1. Retail Pharmacies

            10.6.2. Hospital Pharmacies

            10.6.3. E-Commerce

        10.7. Market Attractiveness, by Distribution Channel

        10.8. Market Value & Volume Forecast, by Country, 2023-2031

            10.8.1. U.S.

            10.8.2. Canada

        10.9. Market Attractiveness Analysis

            10.9.1. By Product Type

            10.9.2. By Application

            10.9.3. By Distribution Channel

            10.9.4. By Country

    11. Europe Pulmonary Drug Delivery Devices Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value & Volume Forecast, by Product Type, 2023-2031

            11.2.1. Dry Powder Inhalers

            11.2.2. Metered Dose Inhalers

            11.2.3. Nebulizers

        11.3. Market Attractiveness, by Product Type

        11.4. Market Value & Volume Forecast, by Application, 2023-2031

            11.4.1. Asthma

            11.4.2. COPD

            11.4.3. Cystic Fibrosis

            11.4.4. Others

        11.5. Market Attractiveness, by Application

        11.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031

            11.6.1. Retail Pharmacies

            11.6.2. Hospital Pharmacies

            11.6.3. E-Commerce

        11.7. Market Attractiveness, by Distribution Channel

        11.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031

            11.8.1. Germany

            11.8.2. U.K.

            11.8.3. France

            11.8.4. Italy

            11.8.5. Spain

            11.8.6. Rest of Europe

        11.9. Market Attractiveness Analysis

            11.9.1. By Product Type

            11.9.2. By Application

            11.9.3. By Distribution Channel

            11.9.4. By Country/Sub-region

    12. Asia Pacific Pulmonary Drug Delivery Devices Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value & Volume Forecast, by Product Type, 2023-2031

            12.2.1. Dry Powder Inhalers

            12.2.2. Metered Dose Inhalers

            12.2.3. Nebulizers

        12.3. Market Attractiveness, by Product Type

        12.4. Market Value & Volume Forecast, by Application, 2023-2031

            12.4.1. Asthma

            12.4.2. COPD

            12.4.3. Cystic Fibrosis

            12.4.4. Others

        12.5. Market Attractiveness, by Application

        12.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031

            12.6.1. Retail Pharmacies

            12.6.2. Hospital Pharmacies

            12.6.3. E-Commerce

        12.7. Market Attractiveness, by Distribution Channel

        12.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031

            12.8.1. China

            12.8.2. Japan

            12.8.3. India

            12.8.4. Australia & New Zealand

            12.8.5. Rest of Asia Pacific

        12.9. Market Attractiveness Analysis

            12.9.1. By Product Type

            12.9.2. By Application

            12.9.3. By Distribution Channel

            12.9.4. By Country/Sub-region

    13. Latin America Pulmonary Drug Delivery Devices Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value & Volume Forecast, by Product Type, 2023-2031

            13.2.1. Dry Powder Inhalers

            13.2.2. Metered Dose Inhalers

            13.2.3. Nebulizers

        13.3. Market Attractiveness, by Product Type

        13.4. Market Value & Volume Forecast, by Application, 2023-2031

            13.4.1. Asthma

            13.4.2. COPD

            13.4.3. Cystic Fibrosis

            13.4.4. Others

        13.5. Market Attractiveness, by Application

        13.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031

            13.6.1. Retail Pharmacies

            13.6.2. Hospital Pharmacies

            13.6.3. E-Commerce

        13.7. Market Attractiveness, by Distribution Channel

        13.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031

            13.8.1. Brazil

            13.8.2. Mexico

            13.8.3. Rest of Latin America

        13.9. Market Attractiveness Analysis

            13.9.1. By Product Type

            13.9.2. By Application

            13.9.3. By Distribution Channel

            13.9.4. By Country/Sub-region

    14. Middle East & Africa Pulmonary Drug Delivery Devices Market Analysis and Forecast

        14.1. Introduction

            14.1.1. Key Findings

        14.2. Market Value & Volume Forecast, by Product Type, 2023-2031

            14.2.1. Dry Powder Inhalers

            14.2.2. Metered Dose Inhalers

            14.2.3. Nebulizers

        14.3. Market Attractiveness, by Product Type

        14.4. Market Value & Volume Forecast, by Application, 2023-2031

            14.4.1. Asthma

            14.4.2. COPD

            14.4.3. Cystic Fibrosis

            14.4.4. Others

        14.5. Market Attractiveness, by Application

        14.6. Market Value & Volume Forecast, by Distribution Channel, 2023-2031

            14.6.1. Retail Pharmacies

            14.6.2. Hospital Pharmacies

            14.6.3. E-Commerce

        14.7. Market Attractiveness, by Distribution Channel

        14.8. Market Value & Volume Forecast, by Country/Sub-region, 2023-2031

            14.8.1. GCC Countries

            14.8.2. South Africa

            14.8.3. Rest of Middle East & Africa

        14.9. Market Attractiveness Analysis

            14.9.1. By Product Type

            14.9.2. By Application

            14.9.3. By Distribution Channel

            14.9.4. By Country/Sub-region

    15. Competition Landscape

        15.1. Market Player - Competition Matrix (By Tier and Size of Companies)

        15.2. Market Share Analysis, by Company (2022)

        15.3. Company Profiles

            15.3.1. AstraZeneca Plc

                15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.1.2. Product Type Portfolio

                15.3.1.3. Financial Overview

                15.3.1.4. SWOT Analysis

                15.3.1.5. Strategic Overview

            15.3.2. Novartis AG

                15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.2.2. Product Type Portfolio

                15.3.2.3. Financial Overview

                15.3.2.4. SWOT Analysis

                15.3.2.5. Strategic Overview

            15.3.3. Boehringer Ingelheim GmbH

                15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.3.2. Product Type Portfolio

                15.3.3.3. Financial Overview

                15.3.3.4. SWOT Analysis

                15.3.3.5. Strategic Overview

            15.3.4. GlaxoSmithKline Plc

                15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.4.2. Product Type Portfolio

                15.3.4.3. Financial Overview

                15.3.4.4. SWOT Analysis

                15.3.4.5. Strategic Overview

            15.3.5. Merck & Co., Inc.

                15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.5.2. Product Type Portfolio

                15.3.5.3. Financial Overview

                15.3.5.4. SWOT Analysis

                15.3.5.5. Strategic Overview

            15.3.6. Teva Pharmaceutical Industries Ltd.

                15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

                15.3.6.2. Product Type Portfolio

                15.3.6.3. Financial Overview

                15.3.6.4. SWOT Analysis

                15.3.6.5. Strategic Overview

    List of Tables

    Table 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031

    Table 02: Global Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031

    Table 03: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031

    Table 04: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031

    Table 05: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Region, 2023-2031

    Table 06: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country, 2023-2031

    Table 07: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031

    Table 08: North America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031

    Table 09: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031

    Table 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031

    Table 11: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 12: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031

    Table 13: Europe Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031

    Table 14: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031

    Table 15: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031

    Table 16: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 17: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031

    Table 18: Asia Pacific Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031

    Table 19: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031

    Table 20: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel, 2023-2031

    Table 21: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 22: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031

    Table 23: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031

    Table 24: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031

    Table 25: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031

    Table 26: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Country/Sub-region, 2023-2031

    Table 27: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Product Type, 2023-2031

    Table 28: Latin America Pulmonary Drug Delivery Devices Market Volume (Million Units) Forecast, by Product Type, 2023-2031

    Table 29: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Application, 2023-2031

    Table 30: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, by Distribution Channel 2023-2031

    List of Figures

    Figure 01: Global Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031

    Figure 02: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 03: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 04: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 05: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031

    Figure 06: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 07: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031

    Figure 08: Global Pulmonary Drug Delivery Devices Market Value Share Analysis, by Region, 2022 and 2031

    Figure 09: Global Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Region, 2023-2031

    Figure 10: North America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031

    Figure 11: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 12: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 13: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 14: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031

    Figure 15: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 16: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031

    Figure 17: North America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country, 2022 and 2031

    Figure 18: North America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country, 2023-2031

    Figure 19: Europe Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031

    Figure 20: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 21: Europe America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 22: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 23: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031

    Figure 24: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 25: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031

    Figure 26: Europe Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 27: Europe Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 28: Asia Pacific Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031

    Figure 29: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 30: Asia Pacific America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 31: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 32: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031

    Figure 33: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 34: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031

    Figure 35: Asia Pacific Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 36: Asia Pacific Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 37: Latin America Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031

    Figure 38: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2022 and 2031

    Figure 39: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 40: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Application, 2022 and 2031

    Figure 41: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Application, 2023-2031

    Figure 42: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 43: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel, 2023-2031

    Figure 44: Latin America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 45: Latin America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 46: Middle East & Africa Pulmonary Drug Delivery Devices Market Value (US$ Mn) Forecast, 2023-2031

    Figure 47: Middle East & Africa America Pulmonary Drug Delivery Devices Market Value Share Analysis, by Product Type, 2023-2031

    Figure 48: Middle East & Africa America Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Product Type, 2023-2031

    Figure 49: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 50: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Distribution Channel 2023-2031

    Figure 51: Middle East & Africa Pulmonary Drug Delivery Devices Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 52: Middle East & Africa Pulmonary Drug Delivery Devices Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 53: Global Pulmonary Drug Delivery Devices Market Share Analysis, by Company (2022)

Copyright © Transparency Market Research, Inc. All Rights reserved